People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mati Therapeutics Inc. | — | Biotechnology | Series A | $13.7M | $28.4M | 2019 |
Deepank Lee Utkhede at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Deepank Lee Utkhede on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Muller | 1 | 2 |
| Deepank Lee Utkede | 1 | 1 |
| Robert Lee Butchofsky | 1 | 1 |
| Cameron Lee Nelson | 1 | 1 |
| Robert Lee Butchofsky II | 1 | 1 |
| Deepank Utkhede | 1 | 1 |
| Robert Butchofsky | 1 | 1 |
| Cameron Nelson | 1 | 1 |
| Joseph Tortorice III | 1 | 1 |
| Chris Lee Muller | 1 | 1 |
| Christopher Lee Muller | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.